Skip to content
10-K

Annual Report

ANTARES PHARMA, INC.

0001016169-22-000028

← back to feed
Filed
Mar 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Feb 28, 2022 170.11M sh
Shares Diluted FY 2021 · Dec 31, 2021 174.73M sh
Shares Diluted FY 2021 · Dec 31, 2020 170.16M sh
Shares Diluted FY 2021 · Dec 31, 2019 162.57M sh
Capex FY 2021 · Dec 31, 2021 $6.62M
Capex FY 2021 · Dec 31, 2020 $9.62M
Capex FY 2021 · Dec 31, 2019 $2.35M
Operating Cash Flow FY 2021 · Dec 31, 2021 $36.62M
Operating Cash Flow FY 2021 · Dec 31, 2020 $21.32M
Operating Cash Flow FY 2021 · Dec 31, 2019 −$10.62M
Long Term Debt FY 2021 · Dec 31, 2021 $18.24M
Long Term Debt FY 2021 · Dec 31, 2020 $24.67M
Short Term Debt FY 2021 · Dec 31, 2021 $1.5M
Short Term Debt FY 2021 · Dec 31, 2020 $16.23M
Short Term Investments FY 2021 · Dec 31, 2021 $1.25M
Short Term Investments FY 2021 · Dec 31, 2020 $0
Cash And Equivalents FY 2021 · Dec 31, 2021 $65.91M
Cash And Equivalents FY 2021 · Dec 31, 2020 $53.14M
Stockholders Equity FY 2021 · Dec 31, 2021 $175.76M
Stockholders Equity FY 2021 · Dec 31, 2020 $119.12M
Stockholders Equity FY 2021 · Dec 31, 2019 $54.5M
Stockholders Equity FY 2021 · Dec 31, 2018 $39M
Current Liabilities FY 2021 · Dec 31, 2021 $58.93M
Current Liabilities FY 2021 · Dec 31, 2020 $63.21M
Total Liabilities FY 2021 · Dec 31, 2021 $81.75M
Total Liabilities FY 2021 · Dec 31, 2020 $93.42M
Current Assets FY 2021 · Dec 31, 2021 $174.27M
Current Assets FY 2021 · Dec 31, 2020 $126.59M
Total Assets FY 2021 · Dec 31, 2021 $257.51M
Total Assets FY 2021 · Dec 31, 2020 $212.53M
Eps Diluted FY 2021 · Dec 31, 2021 $0.26
Eps Diluted FY 2021 · Dec 31, 2020 $0.33
Eps Diluted FY 2021 · Dec 31, 2019 −$0.01
Eps Basic FY 2021 · Dec 31, 2021 $0.27
Eps Basic FY 2021 · Dec 31, 2020 $0.34
Eps Basic FY 2021 · Dec 31, 2019 −$0.01
Sga Expense FY 2021 · Dec 31, 2021 $73.86M
Sga Expense FY 2021 · Dec 31, 2020 $62.76M
Sga Expense FY 2021 · Dec 31, 2019 $61.77M
Rd Expense FY 2021 · Dec 31, 2021 $14.5M
Rd Expense FY 2021 · Dec 31, 2020 $10.12M
Rd Expense FY 2021 · Dec 31, 2019 $10.62M
Net Income FY 2021 · Dec 31, 2021 $46.29M
Net Income FY 2021 · Dec 31, 2020 $56.2M
Net Income FY 2021 · Dec 31, 2019 −$2.03M
Operating Income FY 2021 · Dec 31, 2021 $65.93M
Operating Income FY 2021 · Dec 31, 2020 $13.62M
Operating Income FY 2021 · Dec 31, 2019 $992K
Revenue FY 2021 · Dec 31, 2021 $183.98M
Revenue FY 2021 · Dec 31, 2020 $149.6M
Revenue FY 2021 · Dec 31, 2019 $123.86M